| Variable |
|
HAART n (%) |
Pre HAART n (%) |
Total n (%) |
| Sex |
Male |
101 (49.03) |
65 (31.55) |
166 (40.29) |
| Female |
105 (50.97) |
141 (68.45) |
246 (59.71) |
| Age |
15-29 |
45 (21.85) |
72 (34.95) |
114 (27.67) |
| 30-39 |
98 (47.57) |
85 (41.26) |
186 (45.15) |
| >39 |
63 (30.58) |
49 (23.79) |
112 (27.18) |
| CD4 cell count (in cells/μl) |
<200 |
135 (65.53) |
11 (5.34) |
146 (35.44) |
| |
200-349 |
64 (31.07) |
86 (41.75) |
150 (36.41) |
| |
≥ 350 |
7 (3.40) |
109 (52.91) |
116 (28.15) |
| WHO clinical STAGE |
Stage III or IV |
149 (72.33) |
42 (20.39) |
191 (46.36) |
| |
Stage I or II |
57 (27.67) |
164 (79.61) |
221 (53.64) |
|
